Classified as a distinct species in 1980, Lactobacillus reuteri strains have been used in probiotic formulations for intestinal and urogenital applications. In the former, the primary mechanism of action of L. reuteri SD2112 (ATCC 55730) has been purported to be its ability to produce the antibiotic 3-hydroxypropionaldehyde (3-HPA), also known as reuterin. In the vagina, it has been postulated that probiotic Lactobacillus reuteri RC-14 does not require reuterin production, but mediates a restoration of the normal microbiota via hydrogen peroxide, biosurfactant, lactic acid production and immune modulation. The aim of the present study was to determine if strain RC-14 produced reuterin. Using Polymerase Chain Reaction and DNA dot-blot analyses, numerous Lactobacillus species including RC-14 were screened for the presence of the gene encoding the large subunit of glycerol dehydratase (gldC), the enzyme responsible for reuterin production. In addition, lactobacilli were grown in glycerol-based media and both High Performance Liquid Chromatography (HPLC) and a colourimetric assay were employed to test for the presence of reuterin. L. reuteri RC-14 was determined to be negative for gldC sequences as well as for the production of reuterin when cultured in the presence of glycerol. These findings support that the probiotic effects of L. reuteri RC-14, repeatedly demonstrated during numerous studies of the intestines and vagina, are independent of reuterin production.
Introduction
In 1980, Kandler et al. (16) 
reclassified Lactobacillus fermentum biotype II into
Lactobacillus reuteri species, named after Gerhard Reuter, a German microbiologist who had worked on these organisms. Multiple studies have since shown L. reuteri to be a fairly universal species to the intestinal tracts of not only humans (30) but numerous animal species (24, 32) , and it is frequently isolated from natural environments as well as many meat and dairy products (31, 37) . Based largely upon this ubiquitous and dominant nature, especially amongst healthy individuals and animals, work began to investigate whether strains of L. reuteri could be used to modulate intestinal health. In 1986, a yogurt and milk fermented with a strain of L. reuteri reduced the intestinal coliform count in pigs (26) and it was later proposed by Talarico et al. (35) that the beneficial effects were due to the production of reuterin, more specifically 3-hydroxypropionaldehyde (3-HPA), a by-product of glycerol fermentation (9). A follow-up study characterized reuterin as a broad-spectrum antibiotic, effective against both Gram-positive andnegative strains of bacteria as well as several fungi and protozoa (36). Subsequent to this, L. reuteri strains have been used commercially as probiotic agents ("live microorganisms which when administered in adequate amounts confer a health benefit on the host" (11), with the presumption that they produce reuterin.
However, it has become apparent that this antibiotic compound is not unique to L. reuteri species. Rather, it has been shown to be produced by potentially pathogenic Enterobacter agglomerans, Klebsiella pneumoniae, Citrobacter freundii, Aerobacter aerogenes (3, 25, 34) as well as an intestinal constituent Clostridium butyricum (13). The L. reuteri are not the only Lactobacillus species to produce reuterin, with L. coryniformis cheese isolate also found to be a producer (21) as is L. collinoides (33).
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Escherichia coli C1214. For genomic DNA isolation, lactobacilli were cultured using MRS media (Becton Dickenson [BD] , Oakville, Canada) for 48 hours in anaerobic jars containing CO 2 -generating gas packs (BD). E. coli were cultured aerobically using Brain-Heart Infusion media for 24 hours with shaking (200 rpm). Growth conditions utilized for reuterin production and detection are described in their appropriate sections.
DNA Isolation and PCR Screening
Genomic DNA (gDNA) was isolated from each bacterial strain using Instagene matrix (BioRad, Mississauga, ON, Canada) as per the manufacturer's supplied protocol. Briefly, 1-2 bacterial colonies were isolated from each strain, washed once using sterile water, resuspended in 200µL of InstaGene matrix and incubated at 56°C for 30 minutes. Each suspension was then mixed, incubated in a boiling waterbath for 8 minutes, mixed again and centrifuged at 14,000g for 3 minutes. The resulting supernatant containing the gDNA was removed and stored at -20 o C until use.
All PCR primers and reagents were purchased from Invitrogen (Burlington, ON, Canada) and gel electrophoresis reagents and equipment from BioRad. To amplify a portion of the gene encoding the large subunit of glycerol dehydratase (gldC), degenerate oligonucleotide primers were generated based upon regions of the gene highly conserved across currently published C were also performed to optimize the accuracy and quantity of product produced. Products were separated on 1.2% agarose gels, stained with ethidium bromide and visualized using the GelDoc XR system. Expected product sizes were 728bp for gldC and 201bp for the 16S rRNA gene.
DNA Probe Generation and Dot Blot Analysis
A fragment of the expected 728bp size was amplified from L. reuteri SD2112 gDNA using GDC primers. This fragment was purified using a PCR product purification spin column Absorbance was measured at 560nm using a SpectraMax M5 microplate reader.
Results

GldC Gene Screening
The conversion of glycerol to reuterin is known to be dependent upon the activity of glycerol dehydratase (Gld), an enzyme that dehydrates glycerol into the aldehyde through the removal of one molecule of H 2 O. Thus, we initially wanted to determine whether L. reuteri RC-14 possessed at least one of the genes necessary for its expression. Since gldC encodes the largest subunit of the three subunit enzyme (gldD and gldE encode the other two), we selected it for screening to provide the largest sequence in which to search for highly homologous regions to use in designing oligonucleotide primers and a DNA probe. Based upon the alignment of rDNA-specific DNA probes, respectively (Fig. 2 ). Probes were generated by PCR similarly to PCR screening but with the addition of DIG-labeled dUTP to the nucleotide mix and were evaluated via gel electrophoresis, showing a single band for each migrating approximately 1.3x greater in size from their corresponding unlabeled products due to DIG incorporation (data not shown). The blotting results for the three lactobacilli were shown to be identical to those observed via PCR, supporting that L. reuteri RC-14 does not possess gldC.
HPLC and Colourimetric Assay
To augment the genetic screening results, L. reuteri RC-14 was cultured in glycerol, known to stimulate reuterin production in other L. reuteri strains, to examine whether or not it
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on October 15, 2017 by guest http://aem.asm.org/ Downloaded from could produce the compound under these conditions. Controls L. reuteri 1063 and L. reuteri SD2112 are known to produce reuterin (18,39) while L. reuteri 1068 is known not to produce it with glycerol in the medium. Following a 6 hour glycerol incubation, culture supernatants from all four strains were examined via HPLC (Fig. 3) . As expected, both L. reuteri 1063 and L. reuteri SD2112 showed a peak at the expected elution time for reuterin between glycerol and 1,3-propanediol, whereas L. reuteri 1068 and L. reuteri RC-14 did not. Thus, RC-14 cannot be induced to produce reuterin in the presence of glycerol, conditions known to stimulate its production in other L. reuteri strains.
To support the HPLC results we also monitored the production of reuterin using a colorimetric assay. Two independent isolates of L. reuteri RC-14 were grown to stationary phase in MRS medium at 37C. Cells were pelleted, washed once with phosphate buffered saline (PBS), and resuspended in 15ml of 250 mM glycerol. As a positive control a reuterin producing L. reuteri strain (ATCC 6475) was used. As a negative control we utilized a L. reuteri strain in which the gldC gene was disrupted. As expected, only the positive control L. reuteri strain produced any colorimetric change, indicating the presence of reuterin (OD 560nm =0.628). The two independent isolates of L. reuteri RC-14 (OD 560nm =0.001,0.000), and the gldC mutant (OD 560nm =0.001) did not yield any colorimetric change, indicating a lack of production of reuterin.
Discussion
This study has shown that probiotic L. reuteri RC-14 does not appear to contain a glycerol dehydratase gene, and reuterin production was not detected in this strain. This is important for a number of reasons. Firstly, it indicates that reuterin production is not a
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on October 15, 2017 by guest http://aem.asm.org/ Downloaded from mechanism of action of L. reuteri RC-14 to confer health benefits on the intestine and vagina, as this strain has been shown to do (1, 27) . Thus, the long-held view that specific antimicrobial substances are required for probiotic strains to function, and to displace pathogens, is not supported by the present findings. Rather, probiotic strains such as L. reuteri RC-14, can function in other ways that are antagonistic to pathogen colonization, including modulating host immunity (17, 20) and producing biosurfactants and other anti-adhesive factors (19, 38) . This emphasizes that selection of a strain intended for probiotic use, cannot be solely made based upon presence of an antimicrobial compound. This supports the position of the Food and Agriculture Organization of the United Nations and World Health Organization whose Report (12) states this very point. Yet, the production of antibiotic-type substances is still being used as a means to identify and propagate new probiotic strains (7, 10).
Secondly, it re-emphasizes the diversity of probiotic strains, even within the same species, and shows that species possess different functional properties. Such phenotypic differences between strains has been seen previously, for example with L. rhamnosus GR-1 better functioning in the vagina than L. rhamnosus GG (5) which is better known for its intestinal modalities (15).
In the case of L. reuteri RC-14 and similar strains that do not produce reuterin, several questions arise: Should they become members of a non-reuterin sub-species of L. reuteri and studied further to determine whether additional characteristics warrant their designation as a novel species of Lactobacillus? Or, given that reuterin is produced by strains other than L.
reuteri, should this compound be re-named? The re-classification of bacterial species is generally based on genotypic profiles, even though these too can differ between isolates. However, since strain L. reuteri RC-14 is also genetically closely related to L. fermentum, as shown by ribotying 
